NYSE · Drug Manufacturers - General

Organon & Co (OGN)

$13.64 +0.07%
Add alert
45 In band Daily RSI (14) · 14 Sep 2026

Moving averages

SMA 200$10.41+31.03%

Company profile

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, Hormone replacement therapy (HRT), and anesthesia. The company sells to international markets.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$3.58B
P/E ratio17.49
EPS$0.78
Beta1.518
Dividend yield0.59%
52-week high$13.79
52-week low$5.67

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 53 LLY Lilly(Eli) & Company RSI 43 JNJ Johnson & Johnson RSI 50 BMY Bristol-Myers Squibb Company RSI 45 MRK Merck & Co Inc RSI 52 NVO Novo Nordisk RSI 39 ABBV Abbvie Inc RSI 57 GILD Gilead Sciences Inc RSI 56 AMGN AMGEN Inc RSI 35 GSK GSK Plc RSI 49
Free forever

RSI alerts for OGN

Get an email the moment Organon & Co crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 8:25 AM EDT